Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback